Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The antibacterial activity of fluoroquinolone derivatives: An update (2018–2021)
Yanshu Jia, Liyan Zhao
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113741-113741
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

New Efforts toward Aminothiazolylquinolones with Multitargeting Antibacterial Potential
Jing Zhang, Narsaiah Battini, Jiaming Ou, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 5, pp. 2322-2332
Closed Access | Times Cited: 27
Carvacrol and Thymol Hybrids: Potential Anticancer and Antibacterial Therapeutics
Sijongesonke Peter, Namhla Sotondoshe, Blessing A. Aderibigbe
Molecules (2024) Vol. 29, Iss. 10, pp. 2277-2277
Open Access | Times Cited: 7
1,2,3-Triazole-containing hybrids with potential antibacterial activity against ESKAPE pathogens
Cui Deng, Heng Yan, Jun Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114888-114888
Closed Access | Times Cited: 32
Antibacterial drugs and cyclodextrin inclusion complexes: a patent review
Anamaria Mendonça Santos, Cláudio Carvalho Santana Júnior, José Adão Carvalho Nascimento Júnior, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 3, pp. 349-366
Closed Access | Times Cited: 15
Friend or Foe: Protein Inhibitors of DNA Gyrase
Shengfeng Ruan, Chih-Han Tu, Christina R. Bourne
Biology (2024) Vol. 13, Iss. 2, pp. 84-84
Open Access | Times Cited: 5
Current scenario of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens
Jingyue Gao, Haodong Hou, Feng Gao
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115026-115026
Closed Access | Times Cited: 25
Antibacterial and antibiofilm activity of permanently ionized quaternary ammonium fluoroquinolones
Joanna Fedorowicz, Cristina D. Cruz, Małgorzata Morawska, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115373-115373
Open Access | Times Cited: 13
Synthesis and biological evaluation of ciprofloxacin – 1,2,3-triazole hybrids as antitumor, antibacterial, and antioxidant agents
Samir Al-Taweel, Yousef M. Al-saraireh, Salah A. Al‐Trawneh, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22592-e22592
Open Access | Times Cited: 13
Discovery of benzopyridone cyanoacetates as new type of potential broad-spectrum antibacterial candidates
Jing Zhang, Yi-Min Tan, Shu-Rui Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116107-116107
Closed Access | Times Cited: 12
A Review of the Resistance Mechanisms for β-Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae
Nurul Izzaty Najwa Zahari, Engku Nur Syafirah Engku Abd Rahman, Ahmad Adebayo Irekeola, et al.
Medicina (2023) Vol. 59, Iss. 11, pp. 1927-1927
Open Access | Times Cited: 11
Targeting the cysteine biosynthesis pathway in microorganisms: Mechanism, structure, and drug discovery
Tao Ying, Dandan Zheng, Wei Zou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116461-116461
Closed Access | Times Cited: 4
The piperazine scaffold for novel drug discovery efforts: the evidence to date
Maria Novella Romanelli, Dina Manetti, Laura Braconi, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 9, pp. 969-984
Closed Access | Times Cited: 20
The Antibacterial Activity of Quinazoline and Quinazolinone Hybrids
Zhenghua Li, Li Zhao, Yunqiang Bian, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 12, pp. 1035-1044
Closed Access | Times Cited: 19
Novel ciprofloxacin and norfloxacin-tetrazole hybrids as potential antibacterial and antiviral agents: Targeting S. aureus topoisomerase and SARS-CoV-2-MPro
Jaime Cardoso‐Ortiz, Socorro Leyva‐Ramos, Kim M. Baines, et al.
Journal of Molecular Structure (2022) Vol. 1274, pp. 134507-134507
Open Access | Times Cited: 18
New potent ciprofloxacin-uracil conjugates as DNA gyrase and topoisomerase IV inhibitors against methicillin-resistant Staphylococcus aureus
Mohamed Samir, Mohamed Ramadan, Mostafa Abdelrahman, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 73, pp. 117004-117004
Closed Access | Times Cited: 15
Polymorphism of Pradofloxacin: Crystal Structure Analysis, Stability Study, and Phase Transformation Behavior
Wenlei Li, Lina Zhou, Beiqian Tian, et al.
Pharmaceutical Research (2023) Vol. 40, Iss. 4, pp. 999-1012
Closed Access | Times Cited: 8
Fluoroquinolone-Associated Movement Disorder: A Literature Review
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
Medicines (2023) Vol. 10, Iss. 6, pp. 33-33
Open Access | Times Cited: 8
Advancements in Synthetic Strategies and Biological Effects of Ciprofloxacin Derivatives: A Review
Vuyolwethu Khwaza, Sithenkosi Mlala, Blessing A. Aderibigbe
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4919-4919
Open Access | Times Cited: 2
Cocrystals of tuberculosis antibiotics: Challenges and missed opportunities
Ala’ Salem, Esam Khanfar, Sándor Nagy, et al.
International Journal of Pharmaceutics (2022) Vol. 623, pp. 121924-121924
Open Access | Times Cited: 14
Isatin Conjugates as Antibacterial Agents: A Brief Review
Firoj Hassan, Iqbal Azad, Mohd Asif, et al.
Medicinal Chemistry (2022) Vol. 19, Iss. 5, pp. 413-430
Closed Access | Times Cited: 14
A Series of Spiropyrimidinetriones that Enhances DNA Cleavage Mediated by Mycobacterium tuberculosis Gyrase
Jo Ann W. Byl, Rudolf Mueller, B.D. Bax, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 3, pp. 706-715
Open Access | Times Cited: 7
Antibacterial Properties of Three-Dimensional Flower Cluster ZIF-L Modified by N-Doped Carbon Dots
Jing He, Yuanyuan Xiong, Huaixuan Mu, et al.
Crystals (2023) Vol. 13, Iss. 4, pp. 564-564
Open Access | Times Cited: 7
Recent Advances in Quinolone Hybrids With Potential Antibacterial Activity Against drug-resistant Bacteria
Jun Wang, Shi Yumin, Yan Heng
Future Medicinal Chemistry (2023) Vol. 15, Iss. 6, pp. 555-578
Closed Access | Times Cited: 7
Synthesis, antimicrobial activity, and in silico studies of fluoroquinolones bearing 1,3,4‐oxadiazolyl‐triazole derivatives
Venkateswara Rao Gollapalli, Tejeswara Rao Allaka, Mahesh Kumar Gandla, et al.
Journal of Heterocyclic Chemistry (2023) Vol. 60, Iss. 10, pp. 1666-1683
Closed Access | Times Cited: 7
Amino acid 17 in QRDR of Gyrase A plays a key role in fluoroquinolones susceptibility in mycobacteria
Shuai Wang, Jingran Zhang, Hamza Hameed, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top